Back to Journals » Biologics: Targets and Therapy » Volume 3
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,500 | Dovepress* | 14,500+ | 2,591 | 17,091 | |
Totals | 14,500 | 2,591 | 17,091 | ||
*Since 17 June 2009 +Since July 2016 |
View citations on Google Scholar